LAS VEGAS, NV - A civil trial has resumed after a nearly three-month break in a lawsuit against Teva Pharmaceutical Industries (NASDAQ: TEVA) and their distributor Baxter International (NYSE: BAX) related to Hepatitis-C contamination at a Las Vegas endoscopy clinic.
In the underlying case, plaintiff Stacy Hutchison alleges Teva and Baxter are responsible for her contracting Hepatitis-C, due to the companies' sale of the anesthetic Propofol in large containers, later used by Dr. Dipak Desai for multiple uses with contaminated needles at his endoscopy clinics. Dr. Desai, who has declared bankruptcy, is awaiting trial on criminal charges later this year. Defendants also include Sicor, Inc. and McKesson Medical-Surgical (NYSE: MCK).
Hutchison's attorneys opposed the request, as did the trial court judge, and ultimately the Supreme Court, which wrote "…the record evidence demonstrated that, although this case and related cases received a fair amount of pretrial publicity…it was not of a kind or to the extent that it tainted the jury pool."
The trial is scheduled to continue through at least January 30, with another related endoscopy clinic trial set to begin next month. Despite the unusually lengthy recess, the jury remained under instructions from the court not to independently research or speak about the trial.
Courtroom View Network is providing a gavel-to-gavel video webcast of the Hutchison trial, as it has done for the three other endoscopy clinic trials to date. The case is Stacy Hutchison v. Teva and Baxter, Case Number 08A562216, Clark County Circuit Court, Nevada before Hon. Jerry Wiese.